Stock Spotlight Archives - Page 283 of 379

FridayJul 19, 2019 1:18 pm

QualityStocksNewsBreaks – INmune Bio Inc.’s (NASDAQ: INMB) Innovative Drug Candidate Targets Neuroinflammation to Treat Alzheimer’s Disease

INmune Bio (NASDAQ: INMB) is an immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, such as Alzheimer’s disease (“AD”). A recent article discussing the company reads, “An association between inflammation and Alzheimer’s disease has long been established. Until present, however, this link and the way in which it could be used to offer reliable AD treatments have both been overlooked. Numerous inflammatory markers are found in AD patients, and several studies establish a link between chronic inflammation and the development of AD. . . . XPro1595 works by targeting the microglial immune…

FridayJul 19, 2019 1:03 pm

QualityStocksNewsBreaks – Geyser Brands Inc. (TSX.V: GYSR) Appoints Seasoned Life Sciences Executive to Board of Directors

Geyser Brands (TSX.V: GYSR) announced key appointments to its leadership team recently, including the addition of Dr. Bin Huang to the company’s board of directors (http://ibn.fm/ElFjT). An article discussing the company reads, “Joining the board of directors is Dr. Bin Huang, a seasoned, life-sciences executive with experience in strategy and new business development, financing and public markets, corporate governance and operations management in North America and Asia. She most recently served as CEO of Emerald Health Therapeutics Inc. and has held senior-management roles in both startups and Fortune 500 corporations. Huang holds a PhD in plant cell biology from the…

FridayJul 19, 2019 12:47 pm

QualityStocksNewsBreaks – City View Green Holdings Inc.’s (CSE: CVGR) Retail Arm Expands Reach

City View Green Holdings (CSE: CVGR), together with Budd Hutt, the company’s retail arm, recently announced an agreement to acquire eight retail cannabis store locations in Alberta. An article discussing the company reads, “Budd Hutt plans to initially enter the Canadian retail cannabis marketplace through Alberta and intends to acquire eight pre-license retail cannabis store locations in the Alberta market. These stores have already obtained the appropriate regulatory approvals and are waiting on final approval from Alberta Gaming, Liquor and Cannabis (AGLC). On receipt of AGLC approval, all of the stores will be finished, with the initial five retail store…

FridayJul 19, 2019 12:47 pm

QualityStocksNewsBreaks – QMC Quantum Minerals Corp. (TSX.V: QMC) (OTC: QMCQF) (FSE: 3LQ) Holds Favorable Position as Rising EV Market Boosts Lithium Demand Worldwide

QMC Quantum Minerals (TSX.V: QMC) (OTC: QMCQF) (FSE: 3LQ), a British Columbia-based company focused on the acquisition, exploration and development of natural resource properties, is ideally positioned as demand for lithium rapidly rises alongside the popularity of autonomous electric vehicles (“EVs”). According to a recent BloombergNEF report, the global demand for lithium is projected to reach one million tons per year by 2025 from the current 325,000 tons (http://ibn.fm/2ZwKR). An article discussing the company reads, “According to BloombergNEF’s report titled ‘Electric Vehicle Outlook 2019,’ over two million electric vehicles were sold in the world in 2018, marking a massive increase…

FridayJul 19, 2019 12:10 pm

QualityStocksNewsBreaks – Willow Biosciences Inc. (CSE: WLLW) Employs Proprietary Biosynthetic Processes to Develop Ultra-Pure CBD

Canada-based Willow Biosciences (CSE: WLLW) was recently featured in a video by InvestmentPitch Media detailing how the company utilizes its proprietary biosynthetic processes to deliver high yields of ultra-pure, low-cost cannabinoids. An article further discussing the company reads, “The video (http://ibn.fm/gRZL3) highlights a recent joint development agreement between Alberta, Canada-based Willow Biosciences and Delaware-headquartered Noramco that will build on Willow’s experience in developing manufacturing processes for active pharmaceutical ingredients (‘APIs’) that treat conditions such as cancer, pain and central nervous system disorders, as well as Noramco’s experience in producing high-quality, synthetic cannabinoid APIs for the pharmaceutical and health care industry.…

FridayJul 19, 2019 11:27 am

QualityStocksNewsBreaks – Sugarmade Inc. (SGMD) Staying Ahead of Curve for Anticipated Record Crop in 2019

Sugarmade (OTCQB: SGMD) aims to provide next-generation equipment and techniques to companies that process and extract from industrial hemp for the highly anticipated peak crop in 2019. An article discussing the company reads, “SGMD’s new initiative includes making available to its customers new technology such as water-based sonification extraction, microwaves and other techniques. These machines could reduce the cost of extraction and help cultivators increase output without significant increases in cost. SGMD is not in the hemp cultivation business itself, but it has a business model centered on supporting cultivators. . . . The combination of rising demand and the…

ThursdayJul 18, 2019 3:20 pm

QualityStocksNewsBreaks – Trxade Group Inc. (TRXD) Experiences Strong Start to Fiscal 2019 with Record Revenues, Increased Operating Income

Integrated pharmaceutical logistical services company Trxade Group (OTCQB: TRXD) recently reported record revenues for first quarter 2019 (http://ibn.fm/3NJq6). An article discussing the company reads, “TRXD reported Q1 2019 sales of $1.5 million, as compared to $852,923 in revenues for the same period of the previous year. Operating income grew in Q1 2019 to $171,759 from $98,728 in Q1 2018. Net income reached $125,229 for Q1 2019, as compared to $82,269 for the same period of the previous year. . . . ‘Our 2019 fiscal year is off to a record start and in line with our primary objective of expanding…

ThursdayJul 18, 2019 2:49 pm

QualityStocksNewsBreaks – TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) Adds Top-Tier Executive to Ranks

TransCanna Holdings (CSE: TCAN) (FSE: TH8) recently named Alan R. Applonie as general manager of its Modesto facility (http://ibn.fm/ndEOZ). A recent article discussing the company reads, “The appointment was made after screening of top-tier talent from the industry for a period of six months. Applonie most recently oversaw a major consumer-goods facility that generated approximately $300 million in annual gross revenues. He will be overseeing all of the manufacturing and related activities at the 196,000-square-foot hub, as well as other units being acquired in Stanislaus County. . . . With this one single move, TransCanna has instilled years of experience,…

ThursdayJul 18, 2019 2:39 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) DehydraTECH Consistently Outperforms Industry Standards

Biotechnology company Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) recently reported that clinical lab tests conducted with live animals demonstrated that its new, enhanced version of DehydraTECH(TM) can deliver eight times more CBD into the blood and 19 times more CBD into the brain tissue than standard industry formulations (http://ibn.fm/5y9TR). An article discussing the company reads, “LXRP intends to perform more studies on the enhanced DehydraTECH and focus on optimizing implementation regarding product applications for its licensees. . . . In earlier test results, LXRP announced that original or standard DehydraTECH combined with generic nanotech techniques delivers 1,137% more cannabidiol (CBD)…

Site Search

Company Search

Category: Stock Spotlight